Sodium Valproate Resources and Information
Forms
MHRA - Annual Risk Acknowledgement Form for Female Patients
MHRA - Risk Acknowledgement Form for Male Patients Starting Valproate
Guidance
MHRA - Guide for Healthcare Professionals: Information on the risks of valproate use in all patients
MHRA - Valproate: Review of Safety Data and Expert Advice on Management of Risks
Alerts and Updates
MHRA Drug Safety Update - January 2024
MHRA National Patient Safety Alert - November 2023 (NatPSA/2023/013/MHRA)
Paediatric Patients
RCPCH - Prescribing Valproate to Female Patients Under 18 Years of Age (Jan 2024)
RCPCH - Update for Valproate Prescribing in Paediatric Neurology (Jan 2024)
Community Pharmacy